Oramed Pharmaceuticals Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
ORMP on Nasdaq
Location
1185 Avenue Of The Americas, 3 Rd Floor, New York, New York

There are no Buy or Sell transactions made by insiders since 8/21/2023

Oramed Pharmaceuticals Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Benjamin Shapiro Director $4.32M Jan 4, 2024
Nadav Kidron President and CEO, Director $4.21M Jan 4, 2024
Miriam Kidron Chief Scientific Officer, Director $1.69M Jan 4, 2024
Joshua Hexter Coo & Cbo $1.06M Jan 4, 2024
David Silberman Chief Financial Officer $810K Jan 4, 2024
Yadin Rozov Director $343K Jan 4, 2024
Netanel Derovan Chief Legal Officer $330K May 26, 2023
Michael Rabinowitz Chief Commercial Officer $279K Jan 3, 2023
Michael Rabinowitz Chief Commercial Officer $242K Jan 3, 2022
Leonard Sank Director $217K Jan 4, 2024
Arie Mayer Director $212K Jan 4, 2024
Kevin Rakin Director $103K Mar 21, 2022
Daniel Aghion Director $85.8K Jan 30, 2024
Yehuda Reznick Director $67.5K Jun 6, 2024
Avraham Gabay Chief Financial Officer $0 Jun 21, 2024
Aviad Friedman Director Jan 3, 2022

Recent Insider Transactions by Companies or Individuals for Oramed Pharmaceuticals Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.